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Summary
Objective: Osteophytes are common features of osteoarthritis. This review summarizes the current understanding of the clinical relevance and
biology of osteophytes.
Method: This review summarizes peer-reviewed articles published in the PubMed database before May 2006. In addition this review is sup-
plemented with own data and theoretical considerations with regard to osteophyte formation.
Results: Osteophytes can contribute both to the functional properties of affected joints and to clinical relevant symptoms. Osteophyte forma-
tion is highly associated with cartilage damage but osteophytes can develop without explicit cartilage damage. Osteophytes are mainly derived
from precursor cells in the periosteum and growth factors of the TGFb superfamily appear to play a crucial role in their induction.
Conclusion: Osteophyte formation is an integral component of OA pathogenesis and understanding the biology of osteophyte formation can
give insights in the disturbed homeostasis in OA joints.
ª 2006 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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An osteophyte is ‘‘a ﬁbrocartilage-capped bony outgrowth’’.
Three types of osteophytes are known, the traction spur
at the insertion of tendons and ligaments, the inﬂammatory
spur, represented by the syndesmophyte at the insertion of
ligaments and tendons to bone as can be seen in ankylos-
ing spondylitis; and the genuine osteophyte or osteochon-
drophyte (chondro-osteophyte) arising in the periosteum
overlying the bone at the junction between cartilage and
bone1. In this article we discuss the clinical relevance,
potential function and biology of primarily the osteochondro-
phyte, further called osteophyte, that can be found at
the margins of diarthrodial joints, apophyseal joints and
vertebral bodies and is a common feature of osteoarthritis
(OA).
Clinical relevance
Osteophyte formation is in addition to joint space narrow-
ing, subchondral sclerosis and subchondral cyst formation
one of the main radiographic features of OA and an impor-
tant criterium for this disease. Osteophytes can form early in
the development of OA and can be seen prior to joint space
narrowing.
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can be a source of pain and loss of function. The latter
mainly through nerve compression, limitation of joint mobil-
ity and obstruction of tissues and organs. For example, lum-
bar pain and abdominal pain caused by vertebral
osteophytes have been reported by a number of au-
thors2e5. Several studies have shown a clear relation be-
tween osteophytes of the spine and dysphagia and
breathing problems6e10. In addition, osteophytes of the
spine can be a cause of vocal cord paralysis10e12 and ver-
tebral artery compression by cervical osteophytes has been
reported by Giroux et al.13
Also osteophytes at other sites can be a source of pain
and dysfunction. An association between distally pointing
osteophytes of the acromioclavicular joint and ruptures of
the supraspinatus tendon has been proposed by Petersson
et al.14 A signiﬁcant correlation between medial tibial con-
dyle osteophytes and knee joint pain has been described
in patients with knee OA15 but this is not conﬁrmed by
others16. Moreover, a simple correlation between pain and
osteophytes is not sufﬁcient to demonstrate a causal rela-
tionship. Overall one can conclude that osteophytes can re-
sult in serious medical problems, mainly in the spine, but
that osteophytes can also be present without negative effect
or have even positive effects by increasing the joint surface.
Functional or bystander?
Are osteophytes a functional adaptation or a pathological
phenomenon? It is unclear whether osteophytes develop
because of pathological joint alterations or arise from nor-
mal remodeling processes secondary to joint changes,37
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considered as an adaptation of a joint to instability or as a re-
sult of an altered internal joint milieu resulting in chondro-
genesis of precursor cells in the periosteum and synovial
lining?
The development of osteophytes in the vertebral column
has been shown to be a general indicator of age17. How-
ever, it is difﬁcult to strictly separate ageing form OA due
to the high correlation between ageing and OA. The obser-
vation in humans and animal models that osteophyte forma-
tion can occur without overt cartilage damage seems to
indicate that osteophyte formation and OA are not related
one to one but that osteophyte formation can occur in
‘‘healthy’’ joints, maybe as a result of mechanical stimuli
or ageing. Vise versa full thickness cartilage damage with-
out osteophyte formation has also been shown18. However,
in the latter study it was not clear whether the damage rep-
resents true OA or focal chondral defects. Although carti-
lage damage and osteophyte formation do not correlate
completely, cartilage damage conﬁrmed by joint space nar-
rowing is reported to be highly associated with the presence
of osteophytes15.
In knee joints it has been shown that after a tear of the
anterior cruciate ligament, osteophytes develop anteriorly
and posteriorly and limit translocation of the femur on
the tibia, stabilizing the joint. In primary knee OA removal
of marginal osteophytes signiﬁcantly increased joint mo-
tion, indicating that osteophytes limit the movability of
OA knees19. In hip OA, recuperation of the joint space
has been linked to the development of large osteo-
phytes20. However, the latter does not necessarily indi-
cate resurfacing of the joint with functional cartilage or
return of mobility. These data show that osteophytes
are not non-functional bystanders in all cases but that
they can have constructive roles in a number of OA af-
fected joints.
Osteophyte biology
Osteophytes develop in diarthodial joints (Fig. 1). Dia-
rthrodial joints are constrained by a ligamentous structure
called the joint capsule. Synovium is a membrane contain-
ing macrophages and ﬁbroblast-like cells that cover all the
non-cartilaginous surfaces within the capsule. The syno-
vium is separated from the capsule by the subsynovial layer
that contains blood vessels and nerves. Synovium also
covers the periosteum positioned on the outside of the cor-
tical bone in the joint. The periosteum and synovial lining
contain cells involved in osteophyte formation.
The development of a representative osteophyte originat-
ing at the medial tibia during murine experimental osteoar-
thritis (collagenase-induced OA) is presented in Fig. 2.
Cells in the periosteum covering the bone at the cartilage
and bone boundary are stimulated to proliferate [Fig. 2(b
and c)]. Cells inside the developing osteophyte undergo
chondrogenesis and deposit matrix molecules, such as ag-
grecan, in the tissue [Fig. 2(d)]. The osteophyte remains
covered with a layer of ﬁbroblast-like cells during develop-
ment. Cells in this layer contribute to the growth of the
osteophyte by proliferation and differentiation to chondro-
cytes inside this layer [Fig. 2(e)]. The most central chondro-
cytes further differentiate and hypertrophy [Fig. 2(e and f)].
Hypertrophy of the chondrocytes is followed by endochon-
dral ossiﬁcation, deposition of bone and formation of
marrow cavities [Fig. 2(g)]. A fully developed osteophyte
is integrated with the original subchondral bone and stillshows a outer ﬁbrous layer [Fig. 2(h)]. The top of the osteo-
phyte is covered with cartilage expanding the original carti-
lage surface of the joint [Fig. 2(h)].
OSTEOPHYTES CAN BE RAPIDLY INDUCED
Induction of osteophyte formation can be, at least in ex-
perimental models, a fast process. In murine models of
OA the ﬁrst signs of osteophyte formation can be seen
within 2e3 days. This fast induction of osteophyte formation
is not conﬁned to small rodents. The development of periar-
ticular osteophytes in experimental knee OA in dogs begins
as early as 3 days after induction of the disease process21.
This indicates that at least in these experimental models
osteophyte formation and OA do not have a cause and
effect relationship since overt cartilage damage will not
have developed within this limited time span. Resident cells
lying in the transition zone of bone and articular cartilage
are rapidly triggered to undergo chondrogenesis.
CELL SOURCE OF OSTEOPHYTE PRECURSORS?
What is the cellular source of the osteophyte? Mesenchy-
mal stem cells (MSC) present in the periosteum or synovial
lining are thought to be the precursors of the osteophytes. In
murine experimental OA osteophytes originate primarily
from the periosteum covering the bone at the cartilagee
bone junction. However, also cell populations from the
synovium can be triggered to form cartilage in vitro and
synovium-derived MSC have been shown to be even
more efﬁcient in cartilage formation than bone marrow-
derived MSC22. A comparative study of Sakaguchi et al.
showed that synovium-derived cells were superior in carti-
lage formation compared to cells derived from bone mar-
row, periosteum, skeletal muscle, and adipose tissue23. It
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Fig. 1. Schematic representation of a murine knee joint. Shown are
the sites were osteophytes develop during experimental OA (stars).
T e tibia, P e patella, F e femur, L e ligament, M emenuscus, C e
capsule. Synovium covers all non-articular surfaces within the joint
cavity (=).
239Osteoarthritis and Cartilage Vol. 15, No. 3Fig. 2. Osteophyte formation in experimental murine OA (medial tibia). Cells in the synovial lining are stimulated to proliferate (b and c). Cells
inside the developing osteophyte undergo chondrogenesis and deposit matrix molecules such as aggrecan (d). The most central chondro-
cytes further differentiate and hypertrophy (e and f). This is followed by endochondral ossiﬁcation and formation of marrow cavities (g). A fully
developed osteophyte is integrated with the original subchondral bone and the top of the osteophyte is covered with cartilage expanding the
original cartilage surface of the joint (h) (p e periosteum, AC e articular cartilage, BM e bone marrow cavity).has been shown that although the bone marrow-derived
and synovium-derived MSC shared similar functional prop-
erties their differentiation capacities and transcriptional pro-
ﬁles were dissimilar24. However, De Bari et al. have shown
that human periosteum-derived cells from young as well as
older individuals still can undergo chondrogenesis while
synovium-derived cells failed to form stable ectopic carti-
lage in nude mice indicating a functional difference between
periosteum and synovium-derived cells25e27.
Are osteophytes only the consequence of the recapitula-
tion of endochondral bone formation as can be seen during
development or are also other processes involved. In other
words are osteophytes, as can be found at joint margins,
totally derived from chondrocyte precursors or is there an
attribution of other cells such as (pre)osteoblast? In animal
models of OA it is observed that in addition to chondrogen-
esis and endochondral ossiﬁcation intramembraneous
lamellar bone formation contributes to the deﬁnitive osteo-
phyte. In dogs osteophyte formation has been shown to be
accompanied by hyperplasia of bone21. This bone
develops eventually a mature trabecular structure and be-
comes conﬂuent with the neighboring osteophyte. A similar
pattern of osteophyte formation can be seen in mouse
knee joints with experimental OA, even though not at all
times intramembraneous bone formation signiﬁcantly
contributes to osteophyte formation in murine experimental
OA. These observations suggest that osteophyte formation
is primarily a process of neochondrogenesis of MSC
present in the periosteum at the boneecartilage junction
but that cells derived from the synovial lining andintramembraneous bone formation can contribute to the
deﬁnitive osteophyte.
WHICH FACTORS ARE EXPRESSED DURING THE
DEVELOPMENT OF OSTEOPHYTES?
The expression of growth factors and extracellular matrix
molecules has been studied in human osteophytes and an-
imal models. Transforming growth factor b has been shown
to be expressed by human osteophytes28. In human osteo-
phytes TGFbmRNA expression was found in the superﬁcial
cells in osteophyte cartilage, but it was scarcely present in
the chondrocytes in the degenerative articular cartilage.
We could demonstrate TGFb expression and strong phos-
phorylation of SMAD2, an intracellular signaling molecule
of TGFb, in developing osteophytes in mice29. The ﬁbrous
outer layer of the developing osteophyte strongly expressed
TGFb while SMAD2P could be demonstrated also in more
internal parts of the osteophyte. In hypertrophic chondro-
cytes BMP2 was expressed. These results not only indicate
that TGFb is involved in the initial stages of osteophyte for-
mation but also that later developmental stages could be
under the control of additional factors, like BMPs.
Besides growth factors of the TGFb superfamily other fac-
tors such as Insulin-like Growth Factor-I (IGF-I) have been
shown to be present in developing osteophytes. Okazaki
et al. showed that in a murine OA model (collagenase-
induced OA) both IGF-I and the type I IGF receptor were
detectable in growing osteophytes. Both IGF-I and the
IGF receptor mRNA were coexpressed by proliferating
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sion of the FGF receptor3, PTHrP and the PTH receptor
was demonstrated in chondrocytes in human osteophytes31.
In analogy with embryonic cartilage formation these
factors likely play a role in osteophyte formation in adult
individuals.
An interesting molecule demonstrated to be present in
human osteophytes is leptin32. Serum leptin levels are re-
lated to body fat stores and is suggested to be involved in
both obesity and OA. In animal experiments, leptin induced
the synthesis of IGF-1 and TGFb and strongly stimulated
anabolic activity in chondrocytes32. Leptin can be a connect-
ing factor between obesity on one hand and OA and osteo-
phyte formation on the other.
Expression of growth factors and other soluble mediators
appear to be the driving force of osteophyte formation but
expression of extracellular matrix molecules reﬂects the de-
velopmental stage of the cells and tissues involved. In
human osteophytes cellular differentiation has been ana-
lyzed by investigating collagen expression on mRNA and
protein level33,34. Developing osteophytes are composed
of ﬁbroblasts, mesenchymal prechondrocytes, maturing
chondrocytes, hypertrophic chondrocytes and osteoblast.
Early precartilaginous tissue expressed both mRNA and
protein for type I and type II collagen. The cartilaginous
zones of the osteophytes were characterized by strong
staining of type II collagen, comparable to staining in fetal
cartilage. Mesenchymal prechondrocytes expressed type
IIA procollagen mRNA and maturing chondrocytes ex-
pressed type IIB procollagen mRNA34. Fibrocartilaginous
areas expressed type II as well as type III collagen while
the strongest expression of type I was in bone and in the su-
perﬁcial ﬁbrous layer of the osteophytes. Hypertrophic
chondrocytes, expressing type X collagen, were found in
areas of endochondral ossiﬁcation. Speciﬁc stages of differ-
entiation can be recognized in developing osteophytes
based on collagen expression33.
TRIGGERS OF OSTEOPHYTE FORMATION?
What elicits osteophyte formation can be learned from
in vitro studies on chondrogenesis by MSC or isolated peri-
osteum and from in vivo studies. Are osteophytes induced
as a result of mechanical or biochemical stimulation or by
a combination of both factors? Are mechanical stimuli trans-
ferred to biochemical signals that actually trigger chondro-
genesis? Studies have indicated that cartilage can be
formed by periosteum even in paralyzed limbs and immobi-
lized joints35. This demonstrates that mechanical factors
are not indispensable in the process of chondrogenesis
but does not proof that the initiation of osteophyte formation
is independent of mechanical factors. Most likely mechani-
cal stimuli that are transcribed to biochemical factors on
a cellular level or autonomous biochemical stimuli initiate
the process of chondrogenesis in residing MSC.
Studies from our own group demonstrate that not only the
MSC in the periosteum and synovial membrane are involved
in osteophyte formation but that also macrophage-like
cells contribute to this process. In murine collagenase-
induced OA synovial lining macrophages were selectively
removed from the synovial lining using chlodronate lipo-
somes. This resulted in a signiﬁcant reduction of synovial
activation and osteophyte formation in the treated joints.
Production of growth factors by synovial macrophages
appears to contribute to the process of osteophyte
formation36,37.FACTORS THAT INDUCE OSTEOPHYTES IN VIVO
Many of the factors that have been shown to be ex-
pressed during osteophyte development appear to be
able to induce chondrogenesis, suggesting a role for these
factors during the process of osteophyte formation. Sev-
eral factors belonging to the TGFb superfamily have
been shown to induce osteophyte formation in vivo. The
most potent factor inducing osteophytes appears to be
TGFb. Triple injection of TGFb, 20e200 ng per knee joint
per injection, resulted in impressive osteophyte formation.
Interestingly, the localization of TGFb1-induced osteo-
phytes was very similar to that of osteophytes observed
in murine OA models, suggesting a role for endogenous
TGFb in osteophyte formation during OA38. No differences
in osteophyte formation were observed between TGFb1,
b2, b3. Also adenoviral overexpression of active TGFb
clearly stimulated osteophyte formation although adenovi-
ral overexpression resulted in relatively more marked sy-
novial ﬁbroplasia than direct injection of TGFb39. This
difference can be attributed to the difference in concentra-
tion and duration of TGFb exposure in the two different ex-
perimental settings.
In addition to repeated TGFb injection also repeated in-
jections of BMP2 or BMP9, induced osteophyte formation40.
Osteophytes induced by BMP2 were found at sites in the
joint where the growth plates meet the joint space while os-
teophytes induced by TGFb originated from the periosteum
at sites remote from the growth plates. This shows that
BMP2 targets different types of cells than TGFb. Apparently
TGFb activates MSC in the periosteum while BMP2 stimu-
lates cells that are already committed to the chondro-osteo-
genic pathway. Localization and developmental pattern of
osteophytes induced by TGFb were more similar to OA-re-
lated osteophytes than BMP-induced osteophytes. How-
ever, this does not exclude that BMPs are important in
osteophyte formation at speciﬁc developmental stages of
this structure. Exposing joints to high levels of IGF-I or Con-
nective Tissue Growth Factor (CTGF) did not induce the for-
mation of osteophytes in murine knee joints29,41.
Mesenchymal stem cells can be isolated from synovial
membranes24. Exposure of human MSC from synovium to
TGFb activates the chondrogenic pathway in these cells.
However, it is not clear if TGFb alone is sufﬁcient for induc-
tion of chondrogenesis. Addition of BMP2 and dexametha-
sone to TGFb noticeably increased cartilage formation and
cartilage matrix synthesis22e24.
CHONDROGENESIS IN PERIOSTEUM
Chondrogenesis has been studied in detail in periosteum
and a lot can be learned from those studies. Joyce et al.
have injected TGFb directly into the periosteum of newborn
rat femurs42. Daily injections of TGFb induced chondrogen-
esis that was followed by endochondral bone formation at
these sites. Interestingly, besides induction of cartilage for-
mation also stimulation of intramembraneous bone forma-
tion was observed. The dose of TGFb applied inﬂuenced
the ratio of cartilage to intramembraneous bone formation:
high dosage mainly supported cartilage induction and lower
dosage supported more intramembraneous bone
formation42.
In vitro studies with isolated periosteum show that TGFb
is the most important factor inducing cartilage formation in
these tissues43e49. Miura showed that a short pulse, only
30 min, with a high dosage TGFb was sufﬁcient to induce
chondrogenesis in rabbit periosteum47. However, in a study
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chondrogenesis50.
An important component of media known to stimulate
chondrogenesis in vitro are glucocorticosteroids51e53. Re-
cently it has been shown that expression of SCRG1, a mol-
ecule expressed during chondrogenesis, suppressed
proliferation, and stimulated chondrogenesis of the murine
MSC cell line C3H10T1/2 cells. Expression of SCRG1
was dependent on the presence of dexamethasone in the
culture medium52.
Besides glucocorticoids other factors modulate chondro-
genesis in periosteum. Bone morphogenetic proteins
show conﬂicting results. In rat periosteal cells TGFb alone
did not induce chondrogenesis but BMP2 treatment re-
sulted in type II collagen and aggrecan expression. During
culture the aggregates expressed type X collagen and os-
teocalcin, markers of chondrocyte hypertrophy. Aggregates
treated by BMP2 consisted of numerous hypertrophic chon-
drocytes while culturing with both BMP2 and TGFb blocked
the generation of hypertrophic chondrocytes, indicating that
TGFb modulates chondrocyte terminal differentiation50. Uu-
sitalo and co-workers demonstrated that adenoviral overex-
pression of BMP2 in mouse periosteal cells was sufﬁcient to
induce cartilage formation by mesenchymal cells and sub-
sequent endochondral ossiﬁcation54. In chicken periosteal
cells BMP2 had no effect on chondrogenesis but enhanced
osteogenesis55. These studies appear to indicate that the
effect of BMP2 on chondrogenesis is species dependent
but that in general BMP2 can contribute to chondrogenesis
and osteogenesis. This suggests an essential role for TGFb
in the initiation of chondrogenesis which can be taken over
by BMPs during terminal differentiation of chondrocytes and
endochondral ossiﬁcation of the osteophyte.
IGF-I is an essential growth factor in the metabolism of
differentiated articular cartilage56. In addition to a role of
IGF-I in differentiated cartilage, in rabbit periosteum it has
been shown that IGF-1 increases chondrogenesis in
a dose-dependent manner43,57. A combination of IGF-I
and TGFb gives the strongest stimulation of chondrogene-
sis. A short term incubation with IGF-I increases cartilage
formation and continued IGF-I exposure enhanced cartilage
growth43,57. It appears that IGF-I and TGFb can act in con-
cert to stimulate proliferation and differentiation of periosteal
MSC during chondrogenesis.
Exposure of periosteum to basic Fibroblast Growth Fac-
tor (FGF-2), in the presence of TGFb, also enhances carti-
lage formation43,44,57,58. Addition of FGF-2 during early
stages of culture enhances cell proliferation which results
in increased cartilage formation at later stages. Iwasaki
et al. stimulated periosteum-derived cells form chickens
with TGFb and FGF-244. Basic Fibroblast Growth Factor
clearly stimulated the proliferation of peristeum-derived
cells but inhibited osteochondrogenic differentiation. TGFb
has the opposite effects in these cells. These data indicate
that the main role of FGF-2 in the stimulation of cartilage for-
mation is the expansion of a pool of cells that can be trig-
gered to undergo chondrogenesis by other factors, such
as TGFb.
PHYSICAL FACTORS
Growth factors appear to play a major role in chondrogen-
esis and consequently osteophyte formation. However,
other factors appear to modulate this process. Oxygen ten-
sion and dynamic ﬂuid pressure have been shown to effect
chondrogenesis. Chondrogenesis appears to be, somewhatsurprisingly, maximal at oxygen levels of 12e15% and no
signiﬁcant differences were observed in a range between
12 and 45%59. Only at very high (90%) and very low
(1e5%) oxygen concentrations chondrogenesis was im-
paired. The actual oxygen levels in the joint are in the low
range. Although in vivo chondrogenesis during osteophyte
formation takes place at relatively low oxygen levels these
levels do not appear to stimulate this process. Dynamic ﬂuid
pressure was applied to periosteal explants grown in aga-
rose. Low levels of dynamic ﬂuid pressure enhanced chon-
drogenesis while high levels totally blocked this process60.
The authors did not use TGFb in their culture system to in-
duce chondrogenesis so the observed chondrogenesis was
a result of the applied pressure. The applied pressure can
have a direct effect on the cellular differentiation, induce
chondrogenesis-promoting growth factors or modulate
growth factor binding to the cells.
INHIBITION OF OSTEOPHYTE FORMATION
Chondrogenesis from periosteal MSC is thought to be pri-
mary step in the initiation of osteophyte formation. In vivo
and in vitro studies have shown that TGFb has the potential
to induce chondrogenesis in these cells. However, this does
not prove that TGFb also has this role during OA. To study
the role of endogenous TGFb we blocked its activity, using
the Latency Associated Peptide (LAP), a soluble form of the
type II TGFb receptor and SMAD7 as speciﬁc TGFb inhib-
itors. Blocking TGFb during murine papain-induced OA re-
sulted in signiﬁcant inhibition of osteophyte formation61,62.
These studies show that TGFb is essential in authentic os-
teophyte formation in vivo, it is until now not clear what other
factors contribute to this process in vivo and which are the
crucial factors in human osteophyte formation. In analogy
with other species a role for TGFb in human osteophyte for-
mation can be expected. However, species differences are
known with respect to osteophyte formation. Small rodents
such as mice not only develop osteophytes during OA but
also during experimental arthritis. This indicates that either
the factors present in human and murine joints with arthritis
are dissimilar or that human MSC react differently to these
factors than rodent MSC. The fact that in human OA osteo-
phytes appear indicates that adult human MSC have a gen-
eral ability to develop osteophytes.
PHARMACOLOGIC INHIBITION OF OSTEOPHYTE FORMATION
Several drugs have been reported to inhibit osteophyte
formation in models of experimental osteoarthritis. How-
ever, in most models it appears that inhibition of osteophyte
formation goes hand in hand with reduction in cartilage
damage. The group of Pelletier et al. has reported that in
the canine ACL transection model the NSAIDs tenidap
and carprofen signiﬁcantly reduced osteophyte formation
with a concomitant reduction in the size of the cartilage le-
sions63e66. A similar effect was seen when treating dogs
with the nitric oxide synthase inhibitor L-NIL. The histologi-
cal severity of cartilage lesions and osteophyte formation
was reduced by L-NIL treatment67,68. A theoretical very in-
teresting class of drug in the inhibition of osteophyte forma-
tion is the bisphosphonates. In dogs with ipsilateral ACL
transection it has been shown that treatment with the bi-
sphosphonate NE-10035 markedly reduced formation and
resorption of cancellous bone but had no effect on cartilage
damage or osteophyte formation69. In contrast, treatment of
rats in which OA was induced by transection the ACL with
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pendent manner and inhibited cartilage damage70. The lat-
ter indicates that effects of bisphosphonates are compound
or species dependent.
Conclusions
Osteophyte formation closely resembles the process of
chondrogenesis and endochondral bone formation as can
be seen during embryogenesis. Moreover, cytomorphology
and gene expression patterns indicated that chondrogene-
sis and bone deposition associated with osteophyte forma-
tion bear a close resemblance to healing fracture callus34.
Although the inﬂammatory element of fracture healing is ab-
sent in osteophyte formation it can be concluded that during
osteophyte formation similar signaling pathways are acti-
vated as in healing callus. Moreover, as has been dis-
cussed above factors from activated synovium can
contribute to osteophyte formation. Understanding the biol-
ogy of osteophyte formation can give insights in the dis-
turbed homeostasis of OA joints with OA and ultimately
directions for OA therapy.
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